The document provides information about pharmacology and related topics. It discusses the definition of pharmacology as the study of drugs and their actions on the body. It also covers key concepts such as pharmacokinetics, pharmacodynamics, drug dosage forms, routes of administration, absorption, distribution, metabolism, excretion, and factors that influence drug response.
Pharmacology is the branch of pharmaceutical sciences which is concerned with the study of drug or medication action, where a drug can be broadly defined as any man-made, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Pharmacology is the branch of pharmaceutical sciences which is concerned with the study of drug or medication action, where a drug can be broadly defined as any man-made, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Pharmacology: Class Session 1 and 2 Introduction to PharmacologyMariaJose2001
This is an outline of the basics of Pharmacology. A discussion of how drugs are named, classified and its effects on the person's biochemical processes. It also included the factors influencing drug action and potential drug interactions. At the end, some commonly ysed terminologies were defined.
Pharmacology is study of the substances which interact with living system by activating or inhibiting normal body processes. It includes physical and chemical properties, biochemical and physiological effects, mechanism of action, therapeutic uses and adverse effects of drugs.
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
Pharmacology: Class Session 1 and 2 Introduction to PharmacologyMariaJose2001
This is an outline of the basics of Pharmacology. A discussion of how drugs are named, classified and its effects on the person's biochemical processes. It also included the factors influencing drug action and potential drug interactions. At the end, some commonly ysed terminologies were defined.
Pharmacology is study of the substances which interact with living system by activating or inhibiting normal body processes. It includes physical and chemical properties, biochemical and physiological effects, mechanism of action, therapeutic uses and adverse effects of drugs.
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
The extent and rate at which its active moiety is delivered from pharmaceutical form and becomes available in the systemic circulation
Two related drugs are bioequivalent if they show comparable bioavailability and similar times to achieve peak blood concentrations.
The therapeutic index of a drug is the ratio of the dose that produces toxicity to the dose that produces a clinically desired or effective response in a population of individuals:
LD 50 is a certain dose is expressed in milligrams of test material weight per kilogram of body weight (BW) test animals that produce 50% mortality in the population response of test animals within a certain time frame.
LC 50 is the median lethal concentration or concentration of a substance in a water that can cause death is estimated at 50% of the population of a particular test organism. LC 50 also illustrates the relationship between several concentrations of test solution with the response (mortality) amounted to 50% of the population in the test biota in the specified time period.
CT or chronic toxicity is the toxicity test that includes observation of stimuli that can obstruct or interfere with the test organism's life is continuously in a relatively long period of time. Chronic toxicity tests should consider things related to life events such as the test organism growth, reproduction etc
Introduction of Veterinary pharmacologyQaline Giigii
this course of Introduction of veterinary pharacology was presented by Dr. Osman Abdulahi Farah
Osman Shiine
at Gollis University faculty of Veterinary Medicine
2014
Quality Assurance is of Tremendous Importance in Pharma and Health care sector.
A brief of that is try to explain here..
A Trust of the Customer on Product is solely based on the Effective QA
This extensive presentation contains information about process of drug discovery, clinical trails, pharmacovigilance, approval of the drug, drug discovery timeline, costs involved in developing a new drug, pharmacokinetics, receptors & ligands, pharmacokinetic parameters like plasma concentration, half life, volume of distribution, clearance, steady state plasma concentration, etc.
1.0.bioavailability, pharmacokinetics and efficacy determinationsalummkata1
Bioavailability is a measure of the rate and fraction of the initial dose of a drug that successfully reaches either; the site of action or the bodily fluid domain from which the drug’s intended targets have unimpeded access.
For majority purposes, bioavailability is defined as the fraction of the active form of a drug that reaches systemic circulation unaltered. This definition assumes 100% of the active drug that enters systemic circulation will successfully reach the target site. However, it should be appreciated that this definition is not inclusive of drugs that do not require access to systemic circulation for function (i.e., certain topical drugs). The bioavailability of these drugs is measured by different parameters discussed elsewhere.
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
How to Split Bills in the Odoo 17 POS ModuleCeline George
Bills have a main role in point of sale procedure. It will help to track sales, handling payments and giving receipts to customers. Bill splitting also has an important role in POS. For example, If some friends come together for dinner and if they want to divide the bill then it is possible by POS bill splitting. This slide will show how to split bills in odoo 17 POS.
5. What is PHARMACOLOGY ?
Pharmacokinetics Pharmacodynamics
What the body does to drug What the drug does to body
Pharmacology
Pharmacotherapeutics Pharmacy
The study of the use of drugs Preparing suitable dosage forms
Toxicology
6. PHARMACO THERAPEUTICS
It is a branch of medicine
concerned with the cure of
disease or relief of symptoms
and induces drug treatment.
7. PHARMACY
It is the science of:
•Identification
•Selection
•Preservation
•Standardization
•Compounding, and
•Dispensing of medicinal substances
8. PHARMACOPOEIA
• It is an official code containing a selected
list of the established drugs and medicinal
preparations with descriptions of their
physical properties and tests for their
identity, purity and potency. e.g. IP, BP,
USP, etc.
IP: Indian Pharmacopoeia
BP: British Pharmacopoeia
USP: United states
Pharmacopoeia
9. DRUG
“ Drug is any substance or product that is used
or is intended to be used to modify
physiological systems or pathological states for
the benefit of the recipient .”
10. “Poisons in small doses are the
best medicines; and useful
medicines in too large doses are
poisonous”
William Withering 1789
11. DRUG NAMES
• Chemical…states its chemical composition
and molecular structure.
• Generic…usually suggested by the
manufacturer.
• Official…as listed in the Pharmacopoeia.
(I.P., B.P., U.S.P.)
• Brand…the trade or proprietary name.
12. DRUG NAMES
1,4 benzodiazepine analog
Chemical Name
Generic Name Alprazolam
Official Name Alprazolam, USP
Brand Name Alprax®
13. THE NATURE AND SOURCES OF DRUGS
• Mineral • Liquid paraffin, magnesium
sulfate, etc
• Animal • Insulin, Thyroid, etc.
• Plant • Morphine, Quinine etc
• Synthetic • Aspirin, Sulfonamides, etc.
• Micro-organisms • Penicillin & other antibiotics.
• Drugs produced • Human insulin, human growth,
by genetic hormone etc.
engineering
14. DRUG DEVELOPMENT PROCESS
Chemistry
Synthesis & Purification
Formulation
Animal Pharmacology
Animal Toxicity (Short / Long term)
Studies in Humans
Drug Authorities
Market
16. DOSE Vs DOSAGE
• Dose: The quantity of drug administered
at one time
• 500mg of Paracetamol
• Dosage: The amount of the drug that
should be given over time
• 500 mg Paracetamol TID for 3 days
17. DRUG DOSAGE FORMS
Tablets
Aerosol Capsule
Suspension Injection
Cream Infusion
Solution
18. ROUTES OF DRUG ADMINISTRATION
How the drug is given
Enteral Parenteral Topical
(injectable)
1. Oral 1. Intravenous 1. Intranasal
2. Sublingual 2. Intramuscular 2. Inhalation
3. Rectal 3. Subcutaneous 3. Intravaginal
20. ADVANTAGES AND DISADVANTAGES OF
ORAL, IV, IM AND SC ADMINISTRATION
SAFETY
High Oral > SC > IM > IV Low
CONVENIENCE
High Oral > SC > IM > IV Low
COST
High IV > IM > SC > ORAL Low
21. ADVANTAGES AND DISADVANTAGES OF
ORAL, IV, IM AND SC ADMINISTRATION
BIOAVAILABILITY
High and Reliable IV > IM = SC > ORAL Low &/or Variable
ONSET OF ACTION
Immediate IV > IM > SC > Oral Delayed
PATIENT COMPLIANCE
High Oral > SC > IM > IV Low
22. PHARMACOKINETICS
• The study of what the body does to the drug
• It is the study of absorption, distribution,
metabolism and excretion (ADME) of drugs
• “Fate of drug”
23. PHARMACOKINETICS
•Absorption
How the drug is moved into blood stream from the site of
administration ?
• Distribution
How much drug is moved to various body tissues / organs ?
Depends on blood flow through tissue
• Metabolism
How the drug is altered – broken down ?
• Excretion
How much of the drug is removed from the body ?
24. ABSORPTION
BIOLOGICAL BARRIER
Site of Administration Vascular System
DRUG
25. Drug Absorption of Various Dosage Forms
Oral Preparations
Liquids, elixirs, syrups Fastest
Suspension solutions
Powders
Capsules
Tablets
Coated tablets
Enteric-coated tablets Slowest
26. IV Route
What would the graph of blood level against time
look like?
Blood
level
Time
27. ORAL Route
What would the graph of blood level against time look like?
Blood
level
Time
29. Absorption Metabolism
and and
Distribution Excretion
Blood
level
Time
30. BIOAVAILABILITY
• Bioavailability is a fraction of administered
dose of a drug that reaches the systemic
circulation in the unchanged form.
• Bioavailability of IV route : 100 %
31. BIOAVAILABILITY
Destroyed Not Destroyed Destroyed
in gut absorbed by gut wall by liver
to
Dose systemic
circulation
32. BIOAVAILABILITY
Factors influencing bioavailability
• Dosage forms
• Chemical form
• Dissolution & Absorption of drug
• Route of administration
• Presence of food/drugs in GI tract
• First pass effect
• Extent of drug metabolism before reaching
systemic circulation
35. Concept of Critical Threshold
• MEC (Minimum Effective Concentration):
The minimum level of drug concentration
needed for the desired therapeutic effect to be
present.
• MSC (Maximum Safe Concentration): The
maximum level of drug concentration above
which toxic effects occurs.
OR
• MTC (Minimum Toxic Concentration):
The minimum level of drug concentration
that produces toxic effects.
36. •Maximal Effect: Greatest response that can
be produced by a drug, above which no
further response can be created (sometimes
called “peak effect”)
•Onset: How long before a drug is able to
exert a therapeutic effect
•Duration: How long a drug effect lasts
37. DRUG HALF-LIFE (t1/2 )
• Half life is the time required to reduce the
plasma concentration to 50% of its original
value
• Will determine dosing requirements / how
long a drug will remain in the body
• Used in determining dosing interval
• Goal - Plateau
38. DRUG HALF-LIFE (t1/2 )
110
100
90
Concentration (m g/L)
80
70
60
50
40
30
20
10
0
0 1 2 3 4 5 6 7 8 9
Tim e (hours)
Half-life is the time taken for the concentration of drug in blood to fall by a half
Half-life is 2 hrs
39. DRUG HALF-LIFE (t1/2 )
• 1t 1/2 - 50 % drug is eliminated
• 2 t1/2 - 50+25 (75 %) drug is eliminated
• 3 t1/2 - 50+25 +12.5 (87.5 %) drug is eliminated
• 4 t1/2 - 50+25 +12.5+6.25 (93.7 %) drug is
eliminated
Thus, nearly complete drug elimination occurs in 4-5
half lives.
41. Cmax & Tmax
Cmax
not art nec no C
Tmax
Time
•Cmax - Maximum conc. achieved in the blood
i
•Tmax - Time taken to attain maximum conc.
42. AUC (Area Under Curve)
AUC
• AUC is the area under the plot of plasma
concentration of drug against time after drug
administration.
43. DISTRIBUTION
Distribution is a branch of pharmacokinetics
which describes the reversible transfer of drug
from one location to another within the body.
44. DISTRIBUTION
Locus of Tissue
action reservoirs
“receptors”
Bound Free Bound Free
Systemic
circulation
Absorption Free drug Excretion
Excretion
Bound drug Metabolites
Biotransformation
45. Plasma- Protein Binding
• Many drugs bound to circulating plasma
proteins such as albumin, lipoproteins,
glycoprotein, globulins etc.
• Free form
• Pharmacologically active
• Bound form
• Pharmacologically inactive
Receptor Site
Protein-bound drug
Free Drug
46. Protein Binding
• Drugs can bind with proteins
• Acts as temporary store of drug
• Prolongs it’s action
• Cause prolonged low level of drugs
• Slowly released from bound reservoir
• Delays metabolism
• Delays excretion
• Decreases its entry into CNS
47. Dosing
• Dosing Interval - How often the drug
should be given
• Loading dose – Which puts the plasma
concentration in the therapeutic range
• Maintenance dose - Routine smaller doses
to maintain the steady state (Plateau)
48. METABOLISM
Metabolism = change / biotransformation
The conversion from one chemical form to another
Site of drug biotransformation
• Liver - cytochrome P450 pathways OR microsomal
P450 pathways are used to metabolize most
agents
• Enzymatic alteration of drug structure
Effect of metabolism
80% of drugs become inactive
Inactive drug becomes active: Prodrug
Some drugs do not get metabolised at all
49. METABOLISM
Majority of drugs are metabolized in liver by
enzymes – Cytochrome P 450
Drugs may induce (activate) or inhibit these
enzymes
Drug – Drug interactions
50. First Pass Metabolism
The first-pass metabolism (also known as first-pass
effect or presystemic metabolism) is a phenomenon of
drug metabolism whereby the concentration of a drug
is greatly reduced before it reaches the systemic
circulation.
51. First Pass Metabolism
Hepatic
Swallowed Digestive Rest of
portal Liver
Drug system the body
system
52. First Pass Metabolism
Systems that affect the first pass effect of the drug,
• Enzymes of the gastro intestinal lumen
• Gut wall enzyme
• Bacterial enzymes
• Hepatic enzymes
53. First Pass Metabolism
Effect of first pass metabolism
Part of administered dose made inactive
↓ bioavailability
Drug converted into its active form
• Nitroglycerin when given orally
• Totally inactivated in the liver
• 100% first pass effect
• Always given sublingually
54. Prodrug
Administered in an inactive form
After administration converted into their active form
usually in liver
Designed to improve bioavailability
Examples
Enalapril – Enalaprilate
Ramipril - Ramiprilate
55. METABOLISM
Factors affecting metabolism :
1. Age – Children / Elderly
2. Disease condition – e.g. Liver disease
3. Induction of drug metabolizing enzymes
4. First-pass effect – Nitroglycerin
5. Competition between drugs
6. Genetics
7. Environment e.g. Smoking
56. Excretion
Drugs &/or its metabolites are irreversibly
eliminated from the body
• Elimination of the drug
• Unchanged (Parent form)
• Metabolites
• Routes of excretion
• Kidneys – Urine
• GIT – Stools
• Skin - Perspiration
• Eyes - Tears
57. PHARMACODYNAMICS
• The study of what the drug does to the body
• It is the quantitative study of the biological and
therapeutic effects of drugs.
58. PHARMACODYNAMICS
Drug actions:
• The cellular processes involved in the drug
and cell interaction
Drug effect:
• The physiologic reaction of the body to the
drug
59. PHARMACODYNAMICS
Onset
• The time it takes for the drug to elicit a
therapeutic response
Peak
• The time it takes for a drug to reach its
maximum therapeutic response
Duration
• The time a drug concentration is sufficient
to elicit therapeutic response
60. Four targets of drug action on cells
• Receptors
• Ach receptors / Epinephrine receptors
• Ion Channels
•Voltage gated Na+ / K+ / Ca++
• Enzymes
•Cyclooxygenase / Acetylcholine esterase
• Carriers
•Na+/ K+ pump / Proton Pump
61. Receptors
• Specific macromolecular components of
the cell which when binds with ligand
produces positive or negative biological
response
• Situated - on the surface / inside the cell
62. • Affinity: Inherent ability of the drug to bind with the
receptor
• Efficacy (Intrinsic activity): Inherent ability of the
drug to induce a physiological response
• Potency: An expression of the activity of the drug, in
terms of the concentration or amount needed to
produce a defined effect
63.
64. What drug can do?
All that drugs can do is,
• Mimic the physiological activity of the
body’s own molecules
• Block the physiological activity of the
body’s own molecules
65. Drug at Receptor
• Agonist : It activates a receptor to produce an
effect similar to that of the physiological signal
molecule
• Antagonist : It prevents the action of an agonist
on a receptor but does not have any effect of its
own
• Partial agonist : It activates a receptor to produce
sub maximal effect but antagonizes the action of
full agonist.
66. Agonist v/s Antagonist
• Drug + Receptor EFFECT
• Drug + Receptor Maximum Effect
• Drug = complete or full agonist
• Drug + Receptor Less than maximal effect
• Drug = partial agonist
• Drug + Receptor Block effect
• Drug = Antagonist
67. Effects of combination of drug
• Addition 1+1=2
• Response elicited by combined drugs is equal to
the combined response of the individual drugs
• Synergism 1+1=3
• Two drugs with the same effect are given
together and produce a response greater than
the sum of their individual responses
68. Effects of combination of drug
• Potentiation 0+1=2
• A drug which has no effect enhances the effect
of a second drug
• Antagonism 1+1=0
• Drug inhibits the effect of another drug.
Usually, the antagonist has no inherent activity
69. Factors affecting drug response
• Pharmacological
•Dose & Route of administration
•Duration of treatment
•Co-administration of other drugs
• Individual
•Age & Weight
•Gender
•Pathology
•Diet
70. Indication & Contraindication
• Indication:
A clinical circumstance indicating that the
use of a particular intervention would be
appropriate
• Contraindication:
Any condition which renders a particular
line of treatment improper or undesirable.
71. Adverse drug reaction
What does the term adverse reaction refer to?
A. A life-threatening response to a drug
B. A drug-induced allergy
C. A harmful, noxious, unintended & undesirable
response to a drug
D. An unpredictable response to a drug
72. Adverse drug reactions
Side effect
Toxicity – overdose
Allergic reaction
Physical dependence
Carcinogenic effect
73. Adverse drug reactions: Definitions
• Side Effect
• Unavoidable unintended pharmacodynamic effects that occur
at a therapeutic dose
• Dryness of mouth with Atropine
• Toxic effects
• Result of excessive pharmacological action of the drug due
to overdosage or prolonged use
• Hepatic necrosis from paracetamol overdosage
• Drug intolerance
• Toxic effects of a drug in an individual at therapeutic doses
• Vomiting with a single dose of salicylate
• Drug tolerance
• Decreased response to the same amount of drug after repeated
administration
74. Adverse drug reactions: Definitions
• Cross Tolerance
• Tolerance for a drug that develops after administration of a
different drug
• Tachyphylaxis
• Rapidly occurring tolerance to a drug.
• Cumulative effect
• Increased effectiveness when a drug is given in several doses.
• Drug dependence
• The patient becomes accustomed to the drug’s presence in his
body.
75. Adverse drug reactions: Definitions
• Idiosyncrasy
• Drug effect unique to an individual,
A. a toxic reaction
B. an allergic reaction
C. a reaction peculiar to the patient
D. an anaphylactic reaction
• Drug allergy
• Immunologically mediated reaction
• Symptoms unrelated to pharmacodynamic profile of drug
• Independent of dosage
E.g. Penicillin
• Drug withdrawal symptoms
• Functional disturbances induced by a drug Persists even after
offending drug has been withdrawn
76. Adverse drug reactions: Definitions
• Teratogenecity – induce birth defect
• Capacity of a drug to cause foetal abnormalities
• Thalidomide
• Mutagenic Effect
• Mutagenesis involves alteration of the genotype by
modification of the DNA
• Mutation is carried to the next generations
• Photosensitivity
• Cutaneous reaction resulting from drug induced sensitization
of the skin to UV radiation
• Quinolones
77. Drug Safety–Therapeutic Window
• Therapeutic Index (or Window) measures “how safe a
drug is” or “Margin of safety”
• High therapeutic index = safe
• Low therapeutic index = not so safe
The larger the ratio, the safer the drug
78. Therapeutic Index/Ratio
• Therapeutic Index/Ratio: Is the ratio between lethal
dose (LD) and effective dose (ED) this is useful
measure of safety and efficacy of any drug.
• Lethal dose: The amount of the drug which kills
subjects when it is administered is called lethal dose
• Effective dose: The amount of the drug which
removes sign & symptoms of subjects when it is
administered
79. PLACEBO:
Drug devoid of intrinsic pharmacological activity and
it works by psychological means.
USES : ??????
80. PHASES OF CLINICAL
DEVELOPMENT
• Phase 1: Clinical pharmacology
• Phase 2: Clinical investigation
• Phase 3: Formal therapeutic trials
• Phase 4: Post licensing (marketing)
studies
81. Pregnancy Considerations
• Increased maternal HR, CO and blood volume
• May affect absorption, distribution, effectiveness
• Drugs may cross placenta
• Drugs may cross into breast milk
• Tertatogens
82. Pregnancy Categories
• A: controlled studies in pregnancy (<1 %).
• B: animal studies show no risk; Inadequate
human data.
• C: animal studies show risk, inadequate
human data.
• D: human data show risk, benefit may
outweigh risk.
• X: animal or human data positive for risk. Use
unwarranted.
84. Geriatric Considerations
∀ ⇓ Oral absorption
∀ ⇓ Plasma protein concentration
∀ ⇓ Muscle mass, ⇑ body fat
∀ ⇓ Liver/renal function
• Multiple drugs
• Multiple diseases
85. FUNDAMENTALS OF PHARMACOLOGY
• The rational pharmacological treatment of
any patient requires adequate knowledge
about :
The disease process,
Pharmacodynamic properties of the
drug(s) selected, and
The individual’s handling of the drug(s)
[pharmacokinetics].
86. OPTIMUM DRUG CONCENTRATION
• The concentration must not be too low,
nor too high.
• In the former case, therapeutic failure
may occur, while in the later, adverse
effects may prove troublesome to the
patient.
87. FUNDAMENTALS OF PHARMACOLOGY
• Drugs act by affecting biochemical or
physiological process in the body. Most
drugs act at specific receptors.
• The action of a drug is characterized by
two variables:
The magnitude of the response and
The concentration required to produce the
response.
88. FUNDAMENTALS OF PHARMACOLOGY
• A specific drug acts only at one receptor
but may produce multiple effects due to the
location of the receptor in various organs.
• A selective drug acts on one receptor in a
particular tissue at concentrations that
produce little effect on the receptor in other
organs.
• Most drugs have multiple actions and it is
usually preferable to use more specific or
more selective agents